GB0410966D0 - Treatment of neural disorders - Google Patents

Treatment of neural disorders

Info

Publication number
GB0410966D0
GB0410966D0 GB0410966A GB0410966A GB0410966D0 GB 0410966 D0 GB0410966 D0 GB 0410966D0 GB 0410966 A GB0410966 A GB 0410966A GB 0410966 A GB0410966 A GB 0410966A GB 0410966 D0 GB0410966 D0 GB 0410966D0
Authority
GB
United Kingdom
Prior art keywords
treatment
neural disorders
neural
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0410966A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aimsco Ltd
Original Assignee
Aimsco Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aimsco Ltd filed Critical Aimsco Ltd
Priority to GB0410966A priority Critical patent/GB0410966D0/en
Publication of GB0410966D0 publication Critical patent/GB0410966D0/en
Priority to AU2005230706A priority patent/AU2005230706B2/en
Priority to JP2007506843A priority patent/JP2007531789A/en
Priority to DK05718137.2T priority patent/DK1732648T3/en
Priority to DK09178431.4T priority patent/DK2184085T3/en
Priority to PL12195358T priority patent/PL2591822T3/en
Priority to SG2013028972A priority patent/SG189794A1/en
Priority to CA2562223A priority patent/CA2562223C/en
Priority to MXPA06011554A priority patent/MXPA06011554A/en
Priority to US11/547,644 priority patent/US20080233112A1/en
Priority to EP05718137A priority patent/EP1732648B1/en
Priority to DK12195358.2T priority patent/DK2591822T3/en
Priority to SG200906975-8A priority patent/SG156658A1/en
Priority to NZ550405A priority patent/NZ550405A/en
Priority to PL05718137T priority patent/PL1732648T3/en
Priority to EP09178431.4A priority patent/EP2184085B1/en
Priority to AT05718137T priority patent/ATE451145T1/en
Priority to KR1020067023249A priority patent/KR101226605B1/en
Priority to EP12195358.2A priority patent/EP2591822B1/en
Priority to DE602005018179T priority patent/DE602005018179D1/en
Priority to SG2013028998A priority patent/SG189796A1/en
Priority to ES05718137T priority patent/ES2339035T3/en
Priority to BRPI0509629-4A priority patent/BRPI0509629A/en
Priority to EA200601876A priority patent/EA014225B1/en
Priority to ES12195358.2T priority patent/ES2561291T3/en
Priority to PCT/GB2005/050046 priority patent/WO2005097183A2/en
Priority to PT121953582T priority patent/PT2591822E/en
Priority to IL178490A priority patent/IL178490A/en
Priority to US13/544,026 priority patent/US20130156751A1/en
Priority to US14/141,347 priority patent/US20140105998A1/en
Priority to US14/968,889 priority patent/US20160101131A1/en
Ceased legal-status Critical Current

Links

GB0410966A 2004-04-05 2004-05-17 Treatment of neural disorders Ceased GB0410966D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GB0410966A GB0410966D0 (en) 2004-05-17 2004-05-17 Treatment of neural disorders
PT121953582T PT2591822E (en) 2004-04-05 2005-04-01 Treatment of diseases
PL05718137T PL1732648T3 (en) 2004-04-05 2005-04-01 Treatment of diseases
KR1020067023249A KR101226605B1 (en) 2004-04-05 2005-04-01 Treatment of Diseases
EP09178431.4A EP2184085B1 (en) 2004-04-05 2005-04-01 Treatment of diseases
DK09178431.4T DK2184085T3 (en) 2004-04-05 2005-04-01 Treatment of diseases
PL12195358T PL2591822T3 (en) 2004-04-05 2005-04-01 Treatment of diseases
SG2013028972A SG189794A1 (en) 2004-04-05 2005-04-01 Treatment of diseases
CA2562223A CA2562223C (en) 2004-04-05 2005-04-01 Treatment of autoimmune disorders of the skin with a goat serum obtained from a goat challenged with hiv immunogen
MXPA06011554A MXPA06011554A (en) 2004-04-05 2005-04-01 Treatment of diseases.
US11/547,644 US20080233112A1 (en) 2004-04-05 2005-04-01 Treatment of Diseases
EP05718137A EP1732648B1 (en) 2004-04-05 2005-04-01 Treatment of diseases
DK12195358.2T DK2591822T3 (en) 2004-04-05 2005-04-01 Treatment of diseases
SG200906975-8A SG156658A1 (en) 2004-04-05 2005-04-01 Treatment of diseases
NZ550405A NZ550405A (en) 2004-04-05 2005-04-01 Treatment of diseases
AU2005230706A AU2005230706B2 (en) 2004-04-05 2005-04-01 Treatment of diseases
DK05718137.2T DK1732648T3 (en) 2004-04-05 2005-04-01 disease Treatment
AT05718137T ATE451145T1 (en) 2004-04-05 2005-04-01 TREATMENT OF DISEASES
EA200601876A EA014225B1 (en) 2004-04-05 2005-04-01 Method of treatment of non-demyelinating neural disorder and autoimmune disorder and use of serum goat composition for treating said disorders
EP12195358.2A EP2591822B1 (en) 2004-04-05 2005-04-01 Treatment of diseases
DE602005018179T DE602005018179D1 (en) 2004-04-05 2005-04-01 TREATMENT OF DISEASES
SG2013028998A SG189796A1 (en) 2004-04-05 2005-04-01 Treatment of diseases
ES05718137T ES2339035T3 (en) 2004-04-05 2005-04-01 TREATMENT OF DISEASES.
BRPI0509629-4A BRPI0509629A (en) 2004-04-05 2005-04-01 method of treating a disorder, pharmaceutical composition, use of a composition, and methods of improving neural transmission in unmymyelinated damaged nerves, and of restoring degenerated nerve neural transmission
JP2007506843A JP2007531789A (en) 2004-04-05 2005-04-01 Treatment of disease
ES12195358.2T ES2561291T3 (en) 2004-04-05 2005-04-01 Disease treatment
PCT/GB2005/050046 WO2005097183A2 (en) 2004-04-05 2005-04-01 Treatment of diseases
IL178490A IL178490A (en) 2004-04-05 2006-10-05 Goat serum composition for the treatment of autoimmune disorders
US13/544,026 US20130156751A1 (en) 2004-04-05 2012-07-09 Treatment of diseases
US14/141,347 US20140105998A1 (en) 2004-04-05 2013-12-26 Treatment of diseases
US14/968,889 US20160101131A1 (en) 2004-04-05 2015-12-14 Treatment of diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0410966A GB0410966D0 (en) 2004-05-17 2004-05-17 Treatment of neural disorders

Publications (1)

Publication Number Publication Date
GB0410966D0 true GB0410966D0 (en) 2004-06-16

Family

ID=32527174

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0410966A Ceased GB0410966D0 (en) 2004-04-05 2004-05-17 Treatment of neural disorders

Country Status (1)

Country Link
GB (1) GB0410966D0 (en)

Similar Documents

Publication Publication Date Title
IL175055A0 (en) Combinations useful for the treatment of neuronal disorders
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
ZA200707280B (en) Treatment of bone disorders
PL1890684T3 (en) Treatment of sleep-wake disorders
IL177772A0 (en) Methods and compositions for the treatment of gastrointestinal disorders
ZA200607433B (en) Methods and compositions for the treatment of gastroin-testinal disorders
EP1755584A4 (en) Treatment of myopia
IL182906A0 (en) Method for treatment of movement disorders
EP1786515A4 (en) Treatment of the autonomic nervous system
EP2038004A4 (en) Treatment of neurological disorders via electrical stimulation, and methods related thereto
EP1861126A4 (en) Treatment of protein degradation disorders
IL179508A0 (en) 2-substituted-4- heteroaryl-pyrimidines useful for the treatment of proliferative disorders
IL181706A0 (en) The treatment of inflammatory disorders and pain
IL178815A0 (en) The treatment of respiratory disease
HK1157575A1 (en) Treating neurological disorders
GB0410399D0 (en) The treatment of respiratory disease
ZA200805108B (en) Treatment of neurodegenerative disorders
ZA200802270B (en) Treatment of neurodegenerative disorders
EP1718329A4 (en) Methods of treating skin disorders
GB0426196D0 (en) Methods of treatment
GB0419828D0 (en) The treatment of inflammatroy disorders and pain
IL178990A0 (en) Methods of treating demyelinating disorders
GB0410966D0 (en) Treatment of neural disorders
GB0513413D0 (en) The treatment of inflammatory disorders and pain
GB0417474D0 (en) Treatment of respiratory disorders

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)